Asthma Treatment Market size is expected to grow at a CAGR of 4.27% during the forecast period and the market size is expected to reach nearly US$ 28.15 Bn. by 2029.Asthma Treatment Market Dynamics
The Research Report gives a comprehensive account of the drivers and restraints in the asthma treatment market. Upsurge in the wide variety of FDA-permitted products in parallel to the growing focus between bronchial asthma sufferers concerning greatest care will promotes the steady growth of the market. On the demand side, as recognition regarding pleasant care for the remedy of asthma surges between patients, the acceptance of inhalers and oral drugs is probable to rise.The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report Asthma occurrence has been growing despite improvements in remedy in the beyond many years. Due to this, the global bronchial asthma treatment market is also increasing. Asthma occurrence stages from 3% to 5% in developing countries, to less than 20% in developed international locations, affecting humans of every age. Focus on spreading popularity approximately allergies treatment, including commonplace remedy options which include pressurized meter dose inhalers and dry powder inhalers, is stimulating the worldwide marketplace. Upsurge in the fulfilment price of bronchial asthma remedy the usage of combination remedy, together with a long-appearing muscarinic antagonist-inhaled corticosteroid (LAMA-ICS), prolonged-performing β2-agonist-inhaled corticosteroid (LABA-ICS), and exclusive mixture capsules, and recent regulatory approvals have boosted the acceptance of mixture therapy inside the global asthma remedy marketplace. Daily exposure to the hazardous working surroundings, the influx of pollutants within the air, upsurge in population vulnerable to indoor air pollution, surge in disposable income, growing population of people who smoke, stepped forward healthcare facility, and a growing older populace are some of different the principal factors which can be riding the growth of bronchial asthma marketplace. Though, in current eras, the price-advantages of generic drugs have been pleasing to patients that may pose as a challenge for companies inside the bronchial asthma treatment market. However, High numbers of medical tourism activities observed inside the area are likely to pass on the trend to evolved international locations, which may adversely impact the income of medicine and gadgets related to asthma, thereby inhibiting the increase of the bronchial asthma treatment marketplace area. However, in recent times, the price-advantages of generic drugs have been appealing to patients that may pose as a challenge for manufacturers inside the bronchial asthma treatment marketplace.
Asthma Treatment Market Segment Analysis
Based on treatment type, long-time period asthma control medications segment is anticipated to witness a slow CAGR of around 2.6% at some point of the forecast period (2022-2029). In spite of this, the sales overall performance of those medications would continue to be extensively high compared to brief-relief medicines, as asthma patients are required to comply with a strict remedy regime. Nearly half the people with current asthma had one or more asthma attacks in the past 12 months. According to CDC, there may be prevalence of total 24,753,379 instances of asthma in 2021.Asthma Treatment Market Regional Analysis
North America is projected to dominate the global asthma treatment market throughout the forecast period. This is owing to growing product launches by way of key players. For example, in February 2021, Teva Pharmaceutical Industries Ltd. launched its new QVAR RediHaler inhalation aerosol within the U.S. It is used for the treatment and control of asthma. This breath-actuated aerosol incorporates corticosteroid for the renovation and remedy of bronchial asthma as a prophylactic remedy in patients. North America is contributing marvellous growth opportunities for the future market players, which are anticipated to boost the growth of the asthma treatment market over the coming years. Further, growing patients demand innovative treatments & access to healthcare, development of public healthcare programs in the past years and addition of advance & innovative medicines are some key factors which are supposed to exaggerate the growth of the North America market. Asia Pacific location is predicted to make a leading growth during the forecast period. The growing pollutants on the essential degree, developing variety of humans suffering from bronchial asthma and growing government guide for the allergic reaction treatments are predicted to mark Asia Pacific as a leading region. The objective of the report is to present a comprehensive analysis of the Global Asthma Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Asthma Treatment Market dynamics, structure by analysing the market segments and projects the Global Asthma Treatment Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Asthma Treatment Market make the report investor’s guide.Asthma Treatment Market Scope: Inquire before buying
Global Asthma Treatment Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 20.15 Bn. Forecast Period 2022 to 2029 CAGR: 4.27% Market Size in 2029: US $ 28.15 Bn. Segments Covered: by Route of Administration • Oral • Inhaled • Intravenous • Subcutaneous by Device Type • Inhalers • Dry Powder • Metered Dose • Soft Mist • Nebulizers by Treatment Type • Long-term Asthma Control Medications • Quick-relief (rescue) Medications Asthma Treatment Market, by Regions
• North America • Europe • Asia-Pacific • South America • Middle East and Africa (MEA)Asthma Treatment Market, Key Players
• Mylan N.V. • AstraZeneca plc. • Boehringer Ingelheim International GmbH • F. Hoffmann-La Roche Ltd • GlaxoSmithKline plc. • Merck & Co., Inc. • Novartis AG • Sanofi • Sunovion Pharmaceuticals, Inc. • Teva Pharmaceutical Industries • Philips Healthcare • CareFusion Corporation • Roche Diagnostics • Mylan N.V. • Regeneron • Genentech, Inc. • Sumitomo DainipponFrequently Asked Questions:
1. Which region has the largest share in Global Asthma Treatment Market? Ans: North America region holds the highest share in 2021. 2. What is the growth rate of Global Asthma Treatment Market? Ans: The Global Asthma Treatment Market is growing at a CAGR of 4.27% during forecasting period 2022-2029. 3. What is scope of the Global Asthma Treatment market report? Ans: Global Asthma Treatment Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Asthma Treatment market? Ans: The important key players in the Global Asthma Treatment Market are – Mylan N.V., AstraZeneca plc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., Merck & Co., Inc., Novartis AG, Sanofi, Sunovion Pharmaceuticals, Inc., and Teva Pharmaceutical Industries. 5. What is the study period of this market? Ans: The Global Asthma Treatment Market is studied from 2021 to 2029.
Global Asthma Treatment Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Asthma Treatment Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Asthma Treatment Market Analysis and Forecast 6.1. Global Asthma Treatment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Asthma Treatment Market Analysis and Forecast, By Route of Administration 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Asthma Treatment Market Value Share Analysis, By Route of Administration 7.4. Global Asthma Treatment Market Size (US$ Bn) Forecast, By Route of Administration 7.5. Global Asthma Treatment Market Analysis, By Route of Administration 7.6. Global Asthma Treatment Market Attractiveness Analysis, By Route of Administration 8. Global Asthma Treatment Market Analysis and Forecast, By Device Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Asthma Treatment Market Value Share Analysis, By Device Type 8.4. Global Asthma Treatment Market Size (US$ Bn) Forecast, By Device Type 8.5. Global Asthma Treatment Market Analysis, By Device Type 8.6. Global Asthma Treatment Market Attractiveness Analysis, By Device Type 9. Global Asthma Treatment Market Analysis and Forecast, By Treatment Type 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Asthma Treatment Market Value Share Analysis, By Treatment Type 9.4. Global Asthma Treatment Market Size (US$ Bn) Forecast, By Treatment Type 9.5. Global Asthma Treatment Market Analysis, By Treatment Type 9.6. Global Asthma Treatment Market Attractiveness Analysis, By Treatment Type 10. Global Asthma Treatment Market Analysis, by Region 10.1. Global Asthma Treatment Market Value Share Analysis, by Region 10.2. Global Asthma Treatment Market Size (US$ Bn) Forecast, by Region 10.3. Global Asthma Treatment Market Attractiveness Analysis, by Region 11. North America Asthma Treatment Market Analysis 11.1. Key Findings 11.2. North America Asthma Treatment Market Overview 11.3. North America Asthma Treatment Market Value Share Analysis, By Route of Administration 11.4. North America Asthma Treatment Market Forecast, By Route of Administration 11.4.1. Oral 11.4.2. Inhaled 11.4.3. Intravenous 11.4.4. Subcutaneous 11.5. North America Asthma Treatment Market Value Share Analysis, By Device Type 11.6. North America Asthma Treatment Market Forecast, By Device Type 11.6.1. Inhalers 11.6.2. Dry Powder 11.6.3. Metered Dose 11.6.4. Soft Mist 11.6.5. Nebulizers 11.7. North America Asthma Treatment Market Value Share Analysis, By Treatment Type 11.8. North America Asthma Treatment Market Forecast, By Treatment Type 11.8.1. Long-term Asthma Control Medications 11.8.2. Quick-relief (rescue) Medications 11.9. North America Asthma Treatment Market Value Share Analysis, by Country 11.10. North America Asthma Treatment Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Asthma Treatment Market Analysis, by Country 11.12. U.S. Asthma Treatment Market Forecast, By Route of Administration 11.12.1. Oral 11.12.2. Inhaled 11.12.3. Intravenous 11.12.4. Subcutaneous 11.13. U.S. Asthma Treatment Market Forecast, By Device Type 11.13.1. Inhalers 11.13.2. Dry Powder 11.13.3. Metered Dose 11.13.4. Soft Mist 11.13.5. Nebulizers 11.14. U.S. Asthma Treatment Market Forecast, By Treatment Type 11.14.1. Long-term Asthma Control Medications 11.14.2. Quick-relief (rescue) Medications 11.15. Canada Asthma Treatment Market Forecast, By Route of Administration 11.15.1. Oral 11.15.2. Inhaled 11.15.3. Intravenous 11.15.4. Subcutaneous 11.16. Steel Canada Asthma Treatment Market Forecast, By Device Type 11.16.1. Inhalers 11.16.2. Dry Powder 11.16.3. Metered Dose 11.16.4. Soft Mist 11.16.5. Nebulizers 11.17. Canada Asthma Treatment Market Forecast, By Treatment Type 11.17.1. Long-term Asthma Control Medications 11.17.2. Quick-relief (rescue) Medications 11.18. North America Asthma Treatment Market Attractiveness Analysis 11.18.1. By Route of Administration 11.18.2. By Device Type 11.18.3. By Treatment Type 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Asthma Treatment Market Analysis 12.1. Key Findings 12.2. Europe Asthma Treatment Market Overview 12.3. Europe Asthma Treatment Market Value Share Analysis, By Route of Administration 12.4. Europe Asthma Treatment Market Forecast, By Route of Administration 12.4.1. Oral 12.4.2. Inhaled 12.4.3. Intravenous 12.4.4. Subcutaneous 12.5. Europe Asthma Treatment Market Value Share Analysis, By Device Type 12.6. Europe Asthma Treatment Market Forecast, By Device Type 12.6.1. Inhalers 12.6.2. Dry Powder 12.6.3. Metered Dose 12.6.4. Soft Mist 12.6.5. Nebulizers 12.7. Europe Asthma Treatment Market Value Share Analysis, By Treatment Type 12.8. Europe Asthma Treatment Market Forecast, By Treatment Type 12.8.1. Long-term Asthma Control Medications 12.8.2. Quick-relief (rescue) Medications 12.9. Europe Asthma Treatment Market Value Share Analysis, by Country 12.10. Europe Asthma Treatment Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Asthma Treatment Market Analysis, by Country 12.12. Germany Asthma Treatment Market Forecast, By Route of Administration 12.12.1. Oral 12.12.2. Inhaled 12.12.3. Intravenous 12.12.4. Subcutaneous 12.13. Germany Asthma Treatment Market Forecast, By Device Type 12.13.1. Inhalers 12.13.2. Dry Powder 12.13.3. Metered Dose 12.13.4. Soft Mist 12.13.5. Nebulizers 12.14. Germany Asthma Treatment Market Forecast, By Treatment Type 12.14.1. Long-term Asthma Control Medications 12.14.2. Quick-relief (rescue) Medications 12.15. U.K. Asthma Treatment Market Forecast, By Route of Administration 12.15.1. Oral 12.15.2. Inhaled 12.15.3. Intravenous 12.15.4. Subcutaneous 12.16. U.K. Asthma Treatment Market Forecast, By Device Type 12.16.1. Inhalers 12.16.2. Dry Powder 12.16.3. Metered Dose 12.16.4. Soft Mist 12.16.5. Nebulizers 12.17. U.K. Asthma Treatment Market Forecast, By Treatment Type 12.17.1. Long-term Asthma Control Medications 12.17.2. Quick-relief (rescue) Medications 12.18. France Asthma Treatment Market Forecast, By Route of Administration 12.18.1. Oral 12.18.2. Inhaled 12.18.3. Intravenous 12.18.4. Subcutaneous 12.19. France Asthma Treatment Market Forecast, By Device Type 12.19.1. Inhalers 12.19.2. Dry Powder 12.19.3. Metered Dose 12.19.4. Soft Mist 12.19.5. Nebulizers 12.20. France Asthma Treatment Market Forecast, By Treatment Type 12.20.1. Long-term Asthma Control Medications 12.20.2. Quick-relief (rescue) Medications 12.21. Italy Asthma Treatment Market Forecast, By Route of Administration 12.21.1. Oral 12.21.2. Inhaled 12.21.3. Intravenous 12.21.4. Subcutaneous 12.22. Italy Asthma Treatment Market Forecast, By Device Type 12.22.1. Inhalers 12.22.2. Dry Powder 12.22.3. Metered Dose 12.22.4. Soft Mist 12.22.5. Nebulizers 12.23. Italy Asthma Treatment Market Forecast, By Treatment Type 12.23.1. Long-term Asthma Control Medications 12.23.2. Quick-relief (rescue) Medications 12.24. Spain Asthma Treatment Market Forecast, By Route of Administration 12.24.1. Oral 12.24.2. Inhaled 12.24.3. Intravenous 12.24.4. Subcutaneous 12.25. Spain Asthma Treatment Market Forecast, By Device Type 12.25.1. Inhalers 12.25.2. Dry Powder 12.25.3. Metered Dose 12.25.4. Soft Mist 12.25.5. Nebulizers 12.26. Spain Asthma Treatment Market Forecast, By Treatment Type 12.26.1. Long-term Asthma Control Medications 12.26.2. Quick-relief (rescue) Medications 12.27. Rest of Europe Asthma Treatment Market Forecast, By Route of Administration 12.27.1. Oral 12.27.2. Inhaled 12.27.3. Intravenous 12.27.4. Subcutaneous 12.28. Rest of Europe Asthma Treatment Market Forecast, By Device Type 12.28.1. Inhalers 12.28.2. Dry Powder 12.28.3. Metered Dose 12.28.4. Soft Mist 12.28.5. Nebulizers 12.29. Rest Of Europe Asthma Treatment Market Forecast, By Treatment Type 12.29.1. Long-term Asthma Control Medications 12.29.2. Quick-relief (rescue) Medications 12.30. Europe Asthma Treatment Market Attractiveness Analysis 12.30.1. By Route of Administration 12.30.2. By Device Type 12.30.3. By Treatment Type 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Asthma Treatment Market Analysis 13.1. Key Findings 13.2. Asia Pacific Asthma Treatment Market Overview 13.3. Asia Pacific Asthma Treatment Market Value Share Analysis, By Route of Administration 13.4. Asia Pacific Asthma Treatment Market Forecast, By Route of Administration 13.4.1. Oral 13.4.2. Inhaled 13.4.3. Intravenous 13.4.4. Subcutaneous 13.5. Asia Pacific Asthma Treatment Market Value Share Analysis, By Device Type 13.6. Asia Pacific Asthma Treatment Market Forecast, By Device Type 13.6.1. Inhalers 13.6.2. Dry Powder 13.6.3. Metered Dose 13.6.4. Soft Mist 13.6.5. Nebulizers 13.7. Asia Pacific Asthma Treatment Market Value Share Analysis, By Treatment Type 13.8. Asia Pacific Asthma Treatment Market Forecast, By Treatment Type 13.8.1. Long-term Asthma Control Medications 13.8.2. Quick-relief (rescue) Medications 13.9. Asia Pacific Asthma Treatment Market Value Share Analysis, by Country 13.10. Asia Pacific Asthma Treatment Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Asthma Treatment Market Analysis, by Country 13.12. China Asthma Treatment Market Forecast, By Route of Administration 13.12.1. Oral 13.12.2. Inhaled 13.12.3. Intravenous 13.12.4. Subcutaneous 13.13. China Asthma Treatment Market Forecast, By Device Type 13.13.1. Inhalers 13.13.2. Dry Powder 13.13.3. Metered Dose 13.13.4. Soft Mist 13.13.5. Nebulizers 13.14. China Asthma Treatment Market Forecast, By Treatment Type 13.14.1. Long-term Asthma Control Medications 13.14.2. Quick-relief (rescue) Medications 13.15. India Asthma Treatment Market Forecast, By Route of Administration 13.15.1. Oral 13.15.2. Inhaled 13.15.3. Intravenous 13.15.4. Subcutaneous 13.16. India Asthma Treatment Market Forecast, By Device Type 13.16.1. Inhalers 13.16.2. Dry Powder 13.16.3. Metered Dose 13.16.4. Soft Mist 13.16.5. Nebulizers 13.17. India Asthma Treatment Market Forecast, By Treatment Type 13.17.1. Long-term Asthma Control Medications 13.17.2. Quick-relief (rescue) Medications 13.18. Japan Asthma Treatment Market Forecast, By Route of Administration 13.18.1. Oral 13.18.2. Inhaled 13.18.3. Intravenous 13.18.4. Subcutaneous 13.19. Japan Asthma Treatment Market Forecast, By Device Type 13.19.1. Inhalers 13.19.2. Dry Powder 13.19.3. Metered Dose 13.19.4. Soft Mist 13.19.5. Nebulizers 13.20. Japan Asthma Treatment Market Forecast, By Treatment Type 13.20.1. Long-term Asthma Control Medications 13.20.2. Quick-relief (rescue) Medications 13.21. ASEAN Asthma Treatment Market Forecast, By Route of Administration 13.21.1. Oral 13.21.2. Inhaled 13.21.3. Intravenous 13.21.4. Subcutaneous 13.22. ASEAN Asthma Treatment Market Forecast, By Device Type 13.22.1. Inhalers 13.22.2. Dry Powder 13.22.3. Metered Dose 13.22.4. Soft Mist 13.22.5. Nebulizers 13.23. ASEAN Asthma Treatment Market Forecast, By Treatment Type 13.23.1. Long-term Asthma Control Medications 13.23.2. Quick-relief (rescue) Medications 13.24. Rest of Asia Pacific Asthma Treatment Market Forecast, By Route of Administration 13.24.1. Oral 13.24.2. Inhaled 13.24.3. Intravenous 13.24.4. Subcutaneous 13.25. Rest of Asia Pacific Asthma Treatment Market Forecast, By Device Type 13.25.1. Inhalers 13.25.2. Dry Powder 13.25.3. Metered Dose 13.25.4. Soft Mist 13.25.5. Nebulizers 13.26. Rest of Asia Pacific Asthma Treatment Market Forecast, By Treatment Type 13.26.1. Long-term Asthma Control Medications 13.26.2. Quick-relief (rescue) Medications 13.27. Asia Pacific Asthma Treatment Market Attractiveness Analysis 13.27.1. By Route of Administration 13.27.2. By Device Type 13.27.3. By Treatment Type 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Asthma Treatment Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Asthma Treatment Market Overview 14.3. Middle East & Africa Asthma Treatment Market Value Share Analysis, By Route of Administration 14.4. Middle East & Africa Asthma Treatment Market Forecast, By Route of Administration 14.4.1. Oral 14.4.2. Inhaled 14.4.3. Intravenous 14.4.4. Subcutaneous 14.5. Middle East & Africa Asthma Treatment Market Value Share Analysis, By Device Type 14.6. Middle East & Africa Asthma Treatment Market Forecast, By Device Type 14.6.1. Inhalers 14.6.2. Dry Powder 14.6.3. Metered Dose 14.6.4. Soft Mist 14.6.5. Nebulizers 14.7. Middle East & Africa Asthma Treatment Market Value Share Analysis, By Treatment Type 14.8. Middle East & Africa Asthma Treatment Market Forecast, By Treatment Type 14.8.1. Long-term Asthma Control Medications 14.8.2. Quick-relief (rescue) Medications 14.9. Middle East & Africa Asthma Treatment Market Value Share Analysis, by Country 14.10. Middle East & Africa Asthma Treatment Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Asthma Treatment Market Analysis, by Country 14.12. GCC Asthma Treatment Market Forecast, By Route of Administration 14.12.1. Oral 14.12.2. Inhaled 14.12.3. Intravenous 14.12.4. Subcutaneous 14.13. GCC Asthma Treatment Market Forecast, By Device Type 14.13.1. Inhalers 14.13.2. Dry Powder 14.13.3. Metered Dose 14.13.4. Soft Mist 14.13.5. Nebulizers 14.14. GCC Asthma Treatment Market Forecast, By Treatment Type 14.14.1. Long-term Asthma Control Medications 14.14.2. Quick-relief (rescue) Medications 14.15. South Africa Asthma Treatment Market Forecast, By Route of Administration 14.15.1. Oral 14.15.2. Inhaled 14.15.3. Intravenous 14.15.4. Subcutaneous 14.16. South Africa Asthma Treatment Market Forecast, By Device Type 14.16.1. Inhalers 14.16.2. Dry Powder 14.16.3. Metered Dose 14.16.4. Soft Mist 14.16.5. Nebulizers 14.17. South Africa Asthma Treatment Market Forecast, By Treatment Type 14.17.1. Long-term Asthma Control Medications 14.17.2. Quick-relief (rescue) Medications 14.18. Rest of Middle East & Africa Asthma Treatment Market Forecast, By Route of Administration 14.18.1. Oral 14.18.2. Inhaled 14.18.3. Intravenous 14.18.4. Subcutaneous 14.19. Rest of Middle East & Africa Asthma Treatment Market Forecast, By Device Type 14.19.1. Inhalers 14.19.2. Dry Powder 14.19.3. Metered Dose 14.19.4. Soft Mist 14.19.5. Nebulizers 14.20. Rest of Middle East & Africa Asthma Treatment Market Forecast, By Treatment Type 14.20.1. Long-term Asthma Control Medications 14.20.2. Quick-relief (rescue) Medications 14.21. Middle East & Africa Asthma Treatment Market Attractiveness Analysis 14.21.1. By Route of Administration 14.21.2. By Device Type 14.21.3. By Treatment Type 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Asthma Treatment Market Analysis 15.1. Key Findings 15.2. South America Asthma Treatment Market Overview 15.3. South America Asthma Treatment Market Value Share Analysis, By Route of Administration 15.4. South America Asthma Treatment Market Forecast, By Route of Administration 15.4.1. Oral 15.4.2. Inhaled 15.4.3. Intravenous 15.4.4. Subcutaneous 15.5. South America Asthma Treatment Market Value Share Analysis, By Device Type 15.6. South America Asthma Treatment Market Forecast, By Device Type 15.6.1. Inhalers 15.6.2. Dry Powder 15.6.3. Metered Dose 15.6.4. Soft Mist 15.6.5. Nebulizers 15.7. South America Asthma Treatment Market Value Share Analysis, By Treatment Type 15.8. South America Asthma Treatment Market Forecast, By Treatment Type 15.8.1. Long-term Asthma Control Medications 15.8.2. Quick-relief (rescue) Medications 15.9. South America Asthma Treatment Market Value Share Analysis, by Country 15.10. South America Asthma Treatment Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Asthma Treatment Market Analysis, by Country 15.12. Brazil Asthma Treatment Market Forecast, By Route of Administration 15.12.1. Oral 15.12.2. Inhaled 15.12.3. Intravenous 15.12.4. Subcutaneous 15.13. Brazil Asthma Treatment Market Forecast, By Device Type 15.13.1. Inhalers 15.13.2. Dry Powder 15.13.3. Metered Dose 15.13.4. Soft Mist 15.13.5. Nebulizers 15.14. Brazil Asthma Treatment Market Forecast, By Treatment Type 15.14.1. Long-term Asthma Control Medications 15.14.2. Quick-relief (rescue) Medications 15.15. Mexico Asthma Treatment Market Forecast, By Route of Administration 15.15.1. Oral 15.15.2. Inhaled 15.15.3. Intravenous 15.15.4. Subcutaneous 15.16. Mexico Asthma Treatment Market Forecast, By Device Type 15.16.1. Inhalers 15.16.2. Dry Powder 15.16.3. Metered Dose 15.16.4. Soft Mist 15.16.5. Nebulizers 15.17. Mexico Asthma Treatment Market Forecast, By Treatment Type 15.17.1. Long-term Asthma Control Medications 15.17.2. Quick-relief (rescue) Medications 15.18. Rest of South America Asthma Treatment Market Forecast, By Route of Administration 15.18.1. Oral 15.18.2. Inhaled 15.18.3. Intravenous 15.18.4. Subcutaneous 15.19. Rest of South America Asthma Treatment Market Forecast, By Device Type 15.19.1. Inhalers 15.19.2. Dry Powder 15.19.3. Metered Dose 15.19.4. Soft Mist 15.19.5. Nebulizers 15.20. Rest of South America Asthma Treatment Market Forecast, By Treatment Type 15.20.1. Long-term Asthma Control Medications 15.20.2. Quick-relief (rescue) Medications 15.21. South America Asthma Treatment Market Attractiveness Analysis 15.21.1. By Route of Administration 15.21.2. By Device Type 15.21.3. By Treatment Type 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Merck & Co., Inc. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Mylan N.V. 16.3.3. AstraZeneca plc. 16.3.4. Boehringer Ingelheim International GmbH 16.3.5. F. Hoffmann-La Roche Ltd 16.3.6. GlaxoSmithKline plc. 16.3.7. Novartis AG 16.3.8. Sanofi 16.3.9. Sunovion Pharmaceuticals, Inc. 16.3.10. Teva Pharmaceutical Industries 16.3.11. Philips Healthcare 16.3.12. CareFusion Corporation 16.3.13. Roche Diagnostics 16.3.14. Mylan N.V. 16.3.15. Regeneron 16.3.16. Genentech, Inc. 16.3.17. Sumitomo Dainippon 17. Primary Key Insights